Argo receives FDA approval for walk rehabilitation device

disabled workers

ReWalk is a wearable robotic exoskeleton that enables Spinal Cord Injury sufferers to walk.

Yokne'am based Argo Medical Technologies has received US Food and Drug Administration approval for using its ReWalk device at home and in the community. ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.

“This revolutionary product will have an immediate, life-changing impact on individuals with spinal cord injuries,” said Argo CEO Larry Jasinski. “For the first time individuals with paraplegia will be able to take home this exoskeleton technology, use it every day and maximize on the physiological and psychological benefits we have observed in clinical trials. This is truly the beginning of ‘ReWalking’ as a daily reality in the US.”

ReWalk provides user-initiated mobility through the integration of a wearable brace support, a computer-based control system and motion sensors. The system allows independent, controlled walking while mimicking the natural gait patterns of the legs, similar to that of an able-bodied person. In addition to the ability to stand and walk independently, clinical studies of the ReWalk Rehabilitation system show significant health benefits to the user, on both a physiological and psychological level.

Study data of the ReWalk system indicates potential improvements in cardiovascular health, loss of fat tissue, building of lean muscle mass, and improved bowel function. Feedback from ReWalk users supports these potential benefits and others, such as better pain management, fewer medications, and potentially reduced hospitalizations.

Published by Globes [online], Israel business news - - on June 29, 2014

© Copyright of Globes Publisher Itonut (1983) Ltd. 2014

disabled workers
disabled workers
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018